L51.1 Stevens-Johnson syndrome

Name of the Condition

• Stevens-Johnson syndrome

Summary

Stevens-Johnson syndrome (SJS) is a rare, serious skin and mucous membrane disorder characterized by widespread blistering and skin detachment. It is often triggered by medications or infections and can involve significant systemic involvement, requiring prompt medical attention.

Causes

Most commonly caused by adverse reactions to medications, such as antibiotics, anticonvulsants, or nonsteroidal anti-inflammatory drugs. Infections, particularly herpes simplex virus or Mycoplasma pneumoniae, can also trigger SJS.

Risk Factors

• Use of certain medications, especially those known to cause hypersensitivity reactions.
• Recent infections, particularly viral or bacterial infections.
• A history of prior drug reactions or genetic predisposition to severe cutaneous adverse reactions.

Symptoms

• Rapid onset of red or purplish skin rash, often with blistering.
• Painful skin detachment or sloughing, typically affecting less than 10% of body surface area.
• Mucous membrane involvement, including mouth, eyes, or genital areas, leading to pain or difficulty eating.

Diagnosis

Diagnosis is primarily clinical, based on the characteristic skin and mucous membrane findings. A detailed patient history, including medication use and recent infections, is essential. Skin biopsy may be performed to confirm the diagnosis and rule out other conditions.

Treatment Options

• Immediate discontinuation of the suspected triggering medication.
• Supportive care, including fluid replacement, pain management, and wound care.
• Hospitalization, often in a burn unit, for severe cases requiring intensive monitoring.

Prognosis and Follow-Up

Prognosis depends on the extent of skin involvement and prompt treatment. Most patients recover within weeks to months, but long-term follow-up may be needed to monitor for complications, such as scarring or ocular issues.

Complications

• Severe scarring or skin discoloration.
• Eye problems, including dryness, vision changes, or blindness.
• Respiratory or gastrointestinal tract involvement in severe cases.
• Increased risk of recurrence with future medication exposure.

Lifestyle & Prevention

• Avoid known triggering medications and inform healthcare providers of any history of SJS.
• Practice good hygiene to reduce infection risk.
• Use protective measures, such as sunscreen, to prevent skin damage.

When to Seek Professional Help

Seek immediate medical attention if you develop a rash with blistering, especially after starting a new medication or following an infection. Early intervention is critical to prevent progression.

Tips for Medical Coders

Document the extent of skin detachment, mucous membrane involvement, and any identified triggers (e.g., medication or infection) to support accurate coding. Ensure clinical documentation aligns with the specific criteria for Stevens-Johnson syndrome (L51.1) to reflect the condition appropriately.